Literature DB >> 12509506

Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor.

Bryan Goodwin1, Karine C Gauthier, Michihisa Umetani, Michael A Watson, Matthew I Lochansky, Jon L Collins, Eran Leitersdorf, David J Mangelsdorf, Steven A Kliewer, Joyce J Repa.   

Abstract

Sterol 27-hydroxylase (CYP27A1) is required for bile acid synthesis by both the classical and alternate pathways. Cyp27a1(-/-) mice exhibit a dramatic increase in the activity of cytochrome P450 3A (CYP3A), which catalyzes side-chain hydroxylations of bile acid intermediates, thereby facilitating their excretion in the bile and urine. We examine the role of the nuclear xenobiotic receptor PXR (pregnane X receptor) in this process. We demonstrate that expression of Cyp3a11 and other established PXR target genes is increased in the Cyp27a1(-/-) mice. WhenCyp27a1(-/-) mice are fed a diet containing either cholic acid or chenodeoxycholic acid, expression of CYP7A1, which catalyzes the rate-limiting step in bile acid biosynthesis, is strongly suppressed. In parallel, the induction of Cyp3a11 observed in these mice is reversed, suggesting that bile acid intermediates serve as PXR activators. In support of this hypothesis, three potentially toxic sterols (7alpha-hydroxy-4-cholesten-3-one, 5beta-cholestan-3alpha,7alpha,12alpha-triol, and 4-cholesten-3-one), including two that are known to accumulate in Cyp27a1(-/-) mice, are efficacious activators of mouse PXR. All three compounds are more potent activators of mouse PXR than of human PXR, which may explain in part why humans who lack functional CYP27A1 do not display a corresponding increase in CYP3A activity and are stricken with the disease cerebrotendinous xanthomatosis. Taken together, these results reveal the existence of a feedforward regulatory loop by which potentially toxic bile acid intermediates activate PXR and induce their own metabolism. In addition, this study demonstrates that animal models with alterations in gene expression can be used to identify endogenous ligands for orphan nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12509506      PMCID: PMC140933          DOI: 10.1073/pnas.0237082100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans.

Authors:  I Björkhem; E Leitersdorf
Journal:  Trends Endocrinol Metab       Date:  2000-07       Impact factor: 12.015

2.  Role of LXRs in control of lipogenesis.

Authors:  J R Schultz; H Tu; A Luk; J J Repa; J C Medina; L Li; S Schwendner; S Wang; M Thoolen; D J Mangelsdorf; K D Lustig; B Shan
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

3.  Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver.

Authors:  Y J Wan; D An; Y Cai; J J Repa; T Hung-Po Chen; M Flores; C Postic; M A Magnuson; J Chen; K R Chien; S French; D J Mangelsdorf; H M Sucov
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.

Authors:  J L Staudinger; B Goodwin; S A Jones; D Hawkins-Brown; K I MacKenzie; A LaTour; Y Liu; C D Klaassen; K K Brown; J Reinhard; T M Willson; B H Koller; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module.

Authors:  B Goodwin; E Hodgson; C Liddle
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

6.  Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR.

Authors:  W Xie; J L Barwick; C M Simon; A M Pierce; S Safe; B Blumberg; P S Guzelian; R M Evans
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

7.  Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.

Authors:  A Honda; G Salen; Y Matsuzaki; A K Batta; G Xu; E Leitersdorf; G S Tint; S K Erickson; N Tanaka; S Shefer
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

8.  Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding.

Authors:  J J Repa; E G Lund; J D Horton; E Leitersdorf; D W Russell; J M Dietschy; S D Turley
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

9.  The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis.

Authors:  M Schwarz; A C Wright; D L Davis; H Nazer; I Björkhem; D W Russell
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

10.  Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer.

Authors:  J Grober; I Zaghini; H Fujii; S A Jones; S A Kliewer; T M Willson; T Ono; P Besnard
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

View more
  58 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

2.  Cholesterol detoxification by the nuclear pregnane X receptor.

Authors:  Steven A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 3.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

Review 4.  Caenorhabditis elegans nuclear receptors: insights into life traits.

Authors:  Daniel B Magner; Adam Antebi
Journal:  Trends Endocrinol Metab       Date:  2008-04-10       Impact factor: 12.015

5.  Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts.

Authors:  Matthew D Krasowski; Kazuto Yasuda; Lee R Hagey; Erin G Schuetz
Journal:  Mol Endocrinol       Date:  2005-02-17

Review 6.  How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus.

Authors:  Philippe G Guillem
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

7.  A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4.

Authors:  Xiaochao Ma; Connie Cheung; Kristopher W Krausz; Yatrik M Shah; Ting Wang; Jeffrey R Idle; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2008-09-17       Impact factor: 3.922

8.  Functional characterization of a full length pregnane X receptor, expression in vivo, and identification of PXR alleles, in zebrafish (Danio rerio).

Authors:  Afonso C D Bainy; Akira Kubota; Jared V Goldstone; Roger Lille-Langøy; Sibel I Karchner; Malin C Celander; Mark E Hahn; Anders Goksøyr; John J Stegeman
Journal:  Aquat Toxicol       Date:  2013-09-20       Impact factor: 4.964

9.  Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE-knockout mice.

Authors:  Line Zurkinden; Curzio Solcà; Isabelle A Vögeli; Bruno Vogt; Daniel Ackermann; Sandra K Erickson; Felix J Frey; Dmitri Sviridov; Geneviève Escher
Journal:  FASEB J       Date:  2013-12-10       Impact factor: 5.191

10.  Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.

Authors:  Masaaki Miyata; Yoshiki Matsuda; Masahiro Nomoto; Yuki Takamatsu; Nozomi Sato; Mayumi Hamatsu; Paul A Dawson; Frank J Gonzalez; Yasushi Yamazoe
Journal:  Drug Metab Dispos       Date:  2008-11-06       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.